Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Paysign, Inc. (TPNL)
|
Add to portfolio |
|
|
Price: |
$1.86
| | Metrics |
OS: |
52.8
|
M
| |
8
|
% ROE
|
Market cap: |
$98.1
|
M
| |
-25
|
% ROIC
|
Net cash:
|
$7.67
|
M
| |
$0.15
|
per share
|
EV:
|
$90.5
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$2.9
|
M
| |
31.5
|
x EV/EBITDA
|
EBIT
|
($452.2)
|
k
| |
|
|
EPS |
$0.02
| |
76.3
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 38.0 | 29.5 | 24.1 | 34.7 | 23.4 | 15.2 | 10.4 | 8.1 |
Revenue growth | 29.1% | 22.2% | -30.4% | 48.0% | 53.8% | 46.2% | 28.5% | -21.2% |
Cost of goods sold | 17.1 | 14.8 | 14.8 | 15.4 | 12.0 | 8.5 | 5.9 | 4.0 |
Gross profit | 21.0 | 14.7 | 9.3 | 19.2 | 11.4 | 6.7 | 4.5 | 4.1 |
Gross margin | 55.1% | 49.9% | 38.6% | 55.5% | 48.7% | 44.0% | 43.6% | 50.4% |
Selling, general and administrative | 17.7 | 15.0 | 15.1 | 11.7 | 7.8 | 4.1 | 2.6 | 3.7 |
EBITA | 0.3 | -2.7 | -6.3 | 7.2 | 2.5 | 1.8 | 1.4 | -2.5 |
EBITA margin | 0.9% | -9.3% | -26.0% | 20.7% | 10.6% | 11.6% | 13.0% | -30.9% |
Amortization of intangibles | | | 1.7 | 1.1 | | | | |
EBIT | 0.3 | -2.7 | -8.0 | 6.1 | 2.5 | 1.8 | 1.4 | -2.5 |
EBIT margin | 0.9% | -9.3% | -33.0% | 17.6% | 10.6% | 11.6% | 13.0% | -30.9% |
Pre-tax income | 1.1 | -2.7 | -7.4 | 6.5 | 2.6 | 1.8 | 1.3 | -2.5 |
Income taxes | 0.1 | 0.0 | 0.9 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 9.5% | | | | 0.0% | 0.3% | 0.0% | 0.0% |
Net income | 1.0 | -2.7 | -8.2 | 7.5 | 2.6 | 1.8 | 1.4 | -2.4 |
Net margin | 2.7% | -9.2% | -34.2% | 21.5% | 11.0% | 11.8% | 13.4% | -29.7% |
|
Diluted EPS | $0.02 | ($0.05) | ($0.17) | $0.14 | $0.05 | $0.04 | $0.03 | ($0.06) |
Shares outstanding (diluted) | 52.9 | 51.0 | 49.3 | 54.6 | 52.0 | 48.0 | 43.9 | 39.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|